(Q32077269)

6 July 2017

1 reference

title

Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease (English)

1 reference

6 July 2017

0 references

Maelicke A

1

1 reference

6 July 2017

Samochocki M

2

1 reference

6 July 2017

Jostock R

3

1 reference

6 July 2017

Fehrenbacher A

4

1 reference

6 July 2017

Ludwig J

5

1 reference

6 July 2017

Albuquerque EX

6

1 reference

6 July 2017

Zerlin M

7

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

6 July 2017

published in

Biological Psychiatry

1 reference

6 July 2017

volume

49

1 reference

6 July 2017

issue

3

1 reference

6 July 2017

page(s)

279-288

1 reference

alpha7 nicotinic acetylcholine receptors and modulation of gabaergic synaptic transmission in the hippocampus

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

The cholinergic hypothesis of geriatric memory dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Pharmacology of nicotine: addiction and therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

alpha-Bungarotoxin-sensitive hippocampal nicotinic receptor channel has a high calcium permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Cigarette smoking and major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Cholinergic underactivity in human memory disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: an open study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Chimaeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

The cholinergic hypothesis of Alzheimer's disease: a review of progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

NBD-5-acylcholine: fluorescent analog of acetylcholine and agonist at the neuromuscular junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Acute stress facilitates long-lasting changes in cholinergic gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Nicotinic acetylcholine receptors in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Intravenous nicotine in Alzheimer's disease: a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Nicotine reverses scopolamine-induced impairment of performance in passive avoidance task in rats through its action on the dopaminergic neuronal system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Presynaptic muscarinic receptors in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Stable expression in HEK-293 cells of the rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Physostigmine, galanthamine and codeine act as ‘noncompetitive nicotinic receptor agonists’ on clonal rat pheochromocytoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Basal forebrain neurons in the dementia of Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Nicotine: not just for cigarettes anymore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Tacrine interacts with an allosteric activator site on alpha 4 beta 2 nAChRs in M10 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

7 January 2021

Kinetic properties and regulation of GABAA receptor channels

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

7 January 2021

Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains--in vivo assessment using positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

7 January 2021

Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901109-4

7 January 2021

10.1016/S0006-3223(00)01109-4

Identifiers

DOI

1 reference

6 July 2017

1 reference